Search Media Coverage


To refine your search select a single option or a combination of options:

reset
 

Media Coverage

Displaying Media Coverage item(s) about Healthcare & Life Sciences
1/2/3/4/5Next 100 results
 
  • November 22, 2021
     
    Law360
    A federal judge ruled that the federal government can’t go after United Therapeutics and Novartis over their marking policies limiting the number of drugs sold as a part of a federal drug discount program.
     
    Share
    view
  • October 04, 2021
     
    Law360
    Catalyst Pharmaceuticals Inc. won a decision on Thursday in the Eleventh Circuit, which found that the US Food and Drug Administration unlawfully infringed on an exclusivity period it awarded the company for a drug that treats a rare autoimmune disease when it approved a lower-cost version.
     
    Share
    view
  • June 21, 2021
     
    Healthcare in Europe
    Oliver Mobasser, an associate in the healthcare and life sciences practice, speaks to Healthcare in Europe about the UK's Medicines and Medical Devices Act 2021.
     
    Share
    view
  • April 15, 2021
     
    Law360
    Recent Latham joiner and former Director of the FTC’s Bureau of Competition, partner Ian Conner shares with Law360 his views on the new era of antitrust enforcement, particularly with regard to the technology sector.
     
    Share
    view
  • February 16, 2021
     
    Bloomberg Law
    Scientists at the Astellas Institute for Regenerative Medicine should be considered the sole inventors of three patents covering the production of human stem cells for medical use, a Boston federal court ruled.
     
    Share
    view
  • February 13, 2021
     
    Original Jurisdiction
    Latham honored for a huge trade secrets win for LG Energy Solution at the US International Trade Commission, a significant patent trial victory for Astellas, and the strength of the firm's global Private Equity Practice.
     
    Share
    view
  • February 09, 2021
     
    Law360
    A Massachusetts federal judge removed two former University of Connecticut scientists from a patent for an embryonic stem cell research method, ruling that they did not make inventive contributions.
     
    Share
    view
  • January 08, 2021
     
    Law360
    Steven Feldman brings a wide array of high-stakes litigation experience across industries to the firm’s battle-tested trial team.
     
    Share
    view
  • November 23, 2020
     
    Law360
    The Federal Circuit affirmed a Delaware federal judge's ruling that Hospira's generic version of Par Pharmaceutical's epinephrine emergency allergy product Adrenalin infringes two valid patents covering the drug.
     
    Share
    view
 
1/2/3/4/5Next
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.